← Back to Search

Observational Group for Cardiovascular Disease (BLOOM Trial)

N/A
Recruiting
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 to day 11
Awards & highlights

BLOOM Trial Summary

This pilot study uses a state-of-the-science combination of remote behavioral monitoring, real-time experience sampling, in-lab physiological assessments, and extraction of neighborhood-level characteristics to (1) Examine the impact of daily experience (i.e., racial discrimination, affective states, stress) on health behaviors (i.e., physical activity, sedentary behavior, sleep) at the intrapersonal level among Black women; (2) Test the association between daily behaviors and impairments in biomarkers associated with vascular function/health (i.e., augmented systemic inflammation and oxidative stress, impaired peripheral/cerebral vascular function, increased large artery stiffness), as well as the impact of daily experience on the relationship between behaviors and vascular function; and (3) Explore the influence of neighborhood-level characteristics (i.e., social environment factors: i.e., neighborhood income and poverty, racial composition; and built environment context, such as park density and walkability) on daily experience and health behaviors.

Eligible Conditions
  • Cardiovascular Disease
  • Heart Disease

BLOOM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 to day 11
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 to day 11 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Arterial Stiffness
Blood Flow Measurements (Cerebral Blood Vessels)
Blood Flow Measurements (Large Blood Vessels)
+1 more
Secondary outcome measures
Physical activity

BLOOM Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational GroupExperimental Treatment1 Intervention
Black women enrolled in this study will complete a series of lab-based assessments that evaluate their vascular health, followed by a 10-day free-living monitoring period with mobile and wearable devices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Observational Group
2016
N/A
~10

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor
43 Previous Clinical Trials
4,858 Total Patients Enrolled
American Heart AssociationOTHER
324 Previous Clinical Trials
4,933,698 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~53 spots leftby Oct 2025